Paasa Logo

OTC Markets · Healthcare

Interpace Biosciences stock from India: price, numbers and tax

Interpace Biosciences (IDXG) is not currently available to trade on Paasa; this guide covers the price, the numbers and the Indian tax treatment.

By Paasa · Updated

Interpace Biosciences at a glance

Price
$4.50-$0.93 (17.13%)
Market cap
$26.56M
Day range
$4.50 – $5.39
P/E
0.18
Dividend yield
None
Volume
5.48K
1 month
-10.00%
6 months
-50.00%
YTD
-26.83%
1 year
-2.39%
5 years
-88.39%

Live chart and statistics

Interpace Biosciences statements, FY2021–FY2025

Fiscal year20252024202320222021
Revenue$38.7M$46.9M$40.2M$31.8M$41.3M
Gross profit$24.1M$29.9M$23.9M$18.2M$17.9M
Operating income$4.1M$8.1M$2.8M−$3.8M−$11.7M
Net income$24.6M$6.7M$802.0K−$5.9M−$14.7M
Earnings per share$27.75$7.10$0.95−$6.90−$17.85
EBITDA$4.8M$8.4M$4.4M−$2.3M−$1.3M
Total assets$33.8M$14.8M$13.0M$16.0M$38.4M
Total debt$1.2M$5.9M$11.2M$16.1M$10.7M
Cash and short-term investments$2.5M$1.5M$3.5M$4.8M$3.3M
Shareholders' equity$22.4M−$2.2M−$15.1M−$63.1M−$42.4M
Operating cash flow$5.8M$4.6M$3.8M−$7.7M−$8.7M
Free cash flow$5.5M$3.8M$3.3M−$8.0M−$9.1M
Capital expenditure−$356.0K−$876.0K−$470.0K−$322.0K−$354.0K

Fiscal years as reported, the latest ending 31 Dec 2025. Figures in USD; a dash means the provider reported nothing for that line.

Peer comparison

CompanyTickerPriceMarket cap
Guardant HealthGH$146.76$19.85B
NeoGenomicsNEO$15.16$1.96B
PersonalisPSNL$14.79$1.60B
Castle BiosciencesCSTL$33.78$1.04B

Peers as grouped by the data provider. This is not an investment recommendation.

Analyst price targets

Low
—
High
—
Median
—
Consensus
—

Ratings: 6 buy · 1 hold · 0 sell. Consensus: Buy.

Published sell-side 12-month targets in USD, aggregated by the data provider. They are not Paasa's view and not a forecast.

Why invest in Interpace Biosciences from India

What Interpace Biosciences does

Interpace Biosciences, Inc. is a U.S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system. Interpace Biosciences operates in the Medical - Diagnostics & Research industry within the Healthcare sector.

Hold a dollar asset

Interpace Biosciences shares are priced in US dollars, so a weaker rupee adds to what they're worth in rupees. The rupee depreciated over 85% against the dollar between 2010 and 2025.

Paasa handles the paperwork

Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.

Frequently asked questions

What tax do I pay in India when I sell Interpace Biosciences shares?

In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the USD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain.

Share this guide
Get started

Build wealth in dollars, safeguard against rupee depreciation

Book a short call with our team to understand how Paasa can work for you